Clinical Report: Impact of Timely Nephrology Intervention on AKI Outcomes
Overview
This randomized clinical study investigates the effects of early nephrology consultation triggered by an elevated ESTOP-AKI risk score on acute kidney injury (AKI) outcomes in hospitalized patients.
Background
Acute kidney injury (AKI) is a prevalent condition in hospitalized patients, leading to increased morbidity, mortality, and healthcare costs. Early identification and intervention are critical, as previous trials targeting post-AKI intervention have not consistently shown benefits. The development of machine-learning AKI risk scores, such as the ESTOP-AKI, presents a potential method for early intervention before the onset of AKI.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
The study utilized a gradient boosted machine-learning AKI risk score (ESTOP-AKI) to identify patients at risk of developing AKI.
Patients with an ESTOP-AKI score of at least 0.01 were eligible for early nephrology consultation.
The trial aimed to determine if early nephrology consultation could prevent the development of AKI and improve patient outcomes.
Enrollment for the study was conducted between March 2019 and April 2020, with a pause due to the COVID-19 pandemic.
Patients were randomized to either early nephrology consultation or usual care.
Clinical Implications
Utilizing machine-learning risk scores could enhance early intervention strategies.
Conclusion
This study examines early nephrology intervention in preventing acute kidney injury and improving patient outcomes in hospitalized individuals.
by Matthew M. Churpek, Aiman Fatima, Olasunkanmi Anjorin, Ananya Saravanan, Benjamin S. Ko, Samantha Gunning, Megan L. Prochaska, Tipu S. Puri, Anna L. Zisman, Dana P. Edelson, Mihai C. Giurcanu, Jay L. Koyner, Electronic Signal to Prevent Acute Kidney Injury (ESTOP-AKI) Investigative Team, Katherine Chen, Melody Dias, Joshua Gonzalez, Riley Hamilton, Alissa Kunczt, Christina Li, Kelly Minna, Sharon Trevino
A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.
